The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis

血管紧张素受体阻滞剂 医学 荟萃分析 药理学 毒性 心脏毒性 放射治疗 血管紧张素转换酶 肿瘤科 内科学 生物信息学 生物 血压
作者
Wan-Chuen Liao,Hala Shokr,Corinne Faivre Finn,Clare E. Dempsey,Kaye Janine Williams,Li‐Chia Chen
出处
期刊:Pharmaceuticals [Multidisciplinary Digital Publishing Institute]
卷期号:18 (1): 105-105 被引量:9
标识
DOI:10.3390/ph18010105
摘要

Background/Objectives: ACEIs protect against radiation pneumonitis by reducing angiotensin II production, oxidative stress, and inflammation. This study highlights the significance of concurrent angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) use in radiotherapy by evaluating its impact on radiotherapy-related side effects and survival outcomes, addressing the gap in existing research and providing insights to guide clinical practice in oncology. Methods: The literature was retrieved from the MEDLINE, EMBASE, Web of Science, and Scopus databases from January 2000 to October 2024. Studies on adults (≥18 years) with histologically confirmed cancer, receiving ACEIs or ARBs during radiotherapy, were included. Radiotherapy-related side effects and clinical outcomes were analysed using odds ratios (ORs) and 95% confidence intervals (95%CIs), comparing ACEI/ARB users to non-users. Differences in the median survival time, recurrence, and death rates were also calculated. Results: Sixteen studies (14 cohort studies and two randomised trials) were included. ACEI users exhibited a 50% reduction in the risk of ≥grade 2 radiation pneumonitis (OR: 0.50, 95%CI: 0.32–0.77) in lung cancer and significant reductions in the odds of proctitis (80%, OR: 0.20, 95%CI: 0.12–0.33), haematuria (75%, OR: 0.25, 95%CI: 0.16–0.41), and rectal bleeding (61%, OR: 0.39, 95%CI: 0.30–0.51) in prostate cancer. ACEI/ARB users showed reduced symptomatic radiation necrosis in brain metastases and better 6-month functional independence in supratentorial glioblastoma. Among six studies reporting survival, ACEI/ARB users had longer median survival in early-stage non-small-cell lung cancer and glioblastoma but shorter survival in small cell lung cancer and brain metastases. ARB users had inconsistent survival rates for lung cancer. The varying survival outcomes suggest that ACEIs/ARBs have different effects depending on the cancer type and stage, potentially influenced by cancer-specific factors, treatment protocols, or disease progression. Conclusions: ACEI use is associated with a reduction in radiation pneumonitis, but evidence for other radiotherapy-related toxicity and survival outcomes remains inconsistent across cancer types and severities. Further research should carefully control for confounders.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被心晴采纳,获得10
刚刚
1秒前
闪闪的静枫完成签到,获得积分10
1秒前
3秒前
科研通AI65的应助被qianf采纳,获得10
3秒前
4秒前
清秀网络完成签到,获得积分10
4秒前
Redemption发布了新的文献求助10
5秒前
缥缈含双完成签到,获得积分20
6秒前
所所的应助被浮云采纳,获得10
7秒前
HZB发布了新的文献求助10
7秒前
稳重的尔蝶完成签到 ,获得积分10
7秒前
鱼鱼鱼发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
11秒前
12秒前
西红柿完成签到,获得积分10
13秒前
yugui发布了新的文献求助10
14秒前
心晴发布了新的文献求助10
15秒前
欣喜忆曼发布了新的文献求助10
15秒前
Orange的应助被唱歌的被子采纳,获得10
16秒前
HZB完成签到,获得积分20
17秒前
qianf完成签到,获得积分10
17秒前
18秒前
19秒前
唐林博关注了科研通微信公众号
19秒前
19秒前
田様的应助被Firsterchao采纳,获得10
19秒前
20秒前
20秒前
CipherSage的应助被鱼鱼鱼采纳,获得10
21秒前
23秒前
23秒前
24秒前
25秒前
狂野画板完成签到,获得积分10
25秒前
25秒前
tiptip的应助被yy采纳,获得30
26秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192723
求助须知:如何正确求助?哪些是违规求助? 9579144
关于积分的说明 21863903
捐赠科研通 7792268
什么是DOI,文献DOI怎么找? 3437013
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483864